Aulos Bioscience
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers.
15 employees · est. 2020 · Larkspur, United States
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
68 employees · est. 2019 · Boston, United States
Pyxis Oncology is the older company (2020 vs 2019); Pyxis Oncology is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Aulos Bioscience | Pyxis Oncology |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2019 older |
| Headquarters | ||
| Headquarters | Larkspur, United States | Boston, United States |
| Employees | ||
| Employees | 15 | 68 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Unknown |
| Total Funding | ||
| Total Funding | $60.00M | $392.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development |
| Target Customers | ||
| Target Customers | Not tracked yet | patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers |
| Taxonomy | ||
| Taxonomy | Immuno-oncology, IL-2 Therapeutics, Cancer Care, Immune System, Clinical Candidate, Tumor Killing, Immunosuppression, Toxicity, Solid Tumors, Antibody Development, Cancer Immunotherapies, Biolojic Design, ATP Funding | Antibody-Drug Conjugates, Immunotherapy, Cancer Treatment, Biologics, Tumor Targeting, Immune Suppression Overcoming, Tumor Antigen-Specific TILs, Tumor-Infiltrating Lymphocytes, Cold Tumors, Hot Tumors, Tumor Cell Signaling, Antibody-Based Immunotherapies, Oncology Innovation, Therapeutic Development |
| Website | ||
| Website | aulosbio.com | pyxisoncology.com |
About Aulos Bioscience
Aulos Bioscience is an immuno-oncology company that aims to revolutionize cancer patient care through its computationally designed IL-2 therapeutics. The company's flagship clinical candidate, AU-007, has been engineered to leverage a patient's own IL-2 to induce tumor killing while minimizing assoc...
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...
We will tell you when either one moves
BounceWatch watches Aulos Bioscience and Pyxis Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aulos Bioscience and Pyxis Oncology — by email.
Frequently Asked Questions
Compare Aulos Bioscience with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Aulos Bioscience on 9 Jun 2026, and Pyxis Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.